Placenta Clinical Trials

2 recruitingLast updated: May 5, 2026

There are 41 actively recruiting placenta clinical trials across 21 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Cairo, Egypt, Leuven, Belgium, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Placenta Trials at a Glance

41 actively recruiting trials for placenta are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Cairo, Leuven, and Boston. Lead sponsors running placenta studies include Cairo University, Alexandria University, and Celal Bayar University.

Browse placenta trials by phase

Treatments under study

About Placenta Clinical Trials

Looking for clinical trials for Placenta? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Placenta trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Placenta clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting

Cardiometabolic Disease and Substrate Metabolism

Insulin ResistancePregnancyPregnancy Complications+9 more
University of Tennessee Graduate School of Medicine50 enrolled1 locationNCT07565727
Recruiting

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Pre-EclampsiaPre-Eclampsia; Complicating PregnancyART+12 more
Copenhagen University Hospital, Hvidovre462 enrolled6 locationsNCT07263490
Recruiting

Placental Imaging Techniques

PregnancyUltrasoundPregnancy Outcomes+5 more
Carilion Clinic60 enrolled1 locationNCT06861309
Recruiting

Placental Biology in Health and Disease

PregnancyPre-EclampsiaFetal Growth Restriction (FGR)+3 more
University of Oxford360 enrolled1 locationNCT07470320
Recruiting

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

gastroschisisFetal deathPregnancy Loss+16 more
Medical College of Wisconsin30 enrolled2 locationsNCT03775954
Recruiting
Phase 2

Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)

Intrauterine Growth Restriction (IUGR)Preeclampsia (PE)Placental Insufficiency
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau154 enrolled2 locationsNCT07098975
Recruiting
Not Applicable

Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR

PregnancyPlacenta Accrete SpectrumTourniquets+1 more
Kasr El Aini Hospital100 enrolled1 locationNCT07412925
Recruiting
Not Applicable

Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile

PrematurePlacental Transfusion
Alexandria University160 enrolled1 locationNCT06812507
Recruiting

Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum

placenta accreta
University of California, Los Angeles60 enrolled1 locationNCT07283042
Recruiting
Not Applicable

Characterization of Placental Diffusion

Pregnancy in DiabeticPlacenta Diseases
Hillel Yaffe Medical Center40 enrolled1 locationNCT06992245
Recruiting

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

StillbirthPlacental Insufficiency
Oregon Health and Science University640 enrolled1 locationNCT07144839
Recruiting

Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane

Placenta DiseasesPreterm Premature Rupture of Membrane
Celal Bayar University36 enrolled1 locationNCT06639919
Recruiting

Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications

Monochorionic TwinsCerebroplacental Ratio
Ain Shams Maternity Hospital55 enrolled1 locationNCT06935422
Recruiting
Phase 3

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Pre-EclampsiaIntrauterine Growth RestrictionAspirin+3 more
Centre Hospitalier Intercommunal Creteil500 enrolled20 locationsNCT04356326
Recruiting

Placental Characteristics Within Monochorionic Twin Pregnancies

PlacentaAnatomyMonochorionic Twins
Birmingham Women's NHS Foundation Trust65 enrolled1 locationNCT07124312
Recruiting
Not Applicable

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

emergency cesarean sectionPlacenta PreviaPlacenta Accreta Spectrum+2 more
The Third Affiliated Hospital of Guangzhou Medical University600 enrolled6 locationsNCT07025954
Recruiting
Not Applicable

L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)

PregnancyFetal Growth RestrictionMalaria+3 more
Liverpool School of Tropical Medicine2,960 enrolled1 locationNCT05934318
Recruiting
Not Applicable

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Placenta Accreta Spectrum
University of Pennsylvania15 enrolled1 locationNCT06512181
Recruiting

Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome

PreeclampsiaVasa PreviaFetal Growth Restriction (FGR)+3 more
Aristotle University Of Thessaloniki12,084 enrolled6 locationsNCT06918236
Recruiting

Effects of Tuberculosis Infection on Development and Function of the Placenta

Pregnancy RelatedTuberculosis InfectionPlacenta Diseases
Lund University500 enrolled1 locationNCT06352970